Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    Fresolimumab
Show Display Options
Rank Status Study
1 Completed Fresolimumab In Systemic Sclerosis
Condition: Diffuse Systemic Sclerosis
Intervention: Drug: Fresolimumab
2 Active, not recruiting Fresolimumab and Radiotherapy in Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: fresolimumab (GC1008);   Radiation: Radiation Therapy
3 Active, not recruiting A Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS)
Condition: Primary Focal Segmental Glomerulosclerosis
Interventions: Drug: fresolimumab;   Drug: Placebo
4 Completed Safety and Imaging Study of GC1008 in Glioma
Condition: Primary Brain Tumors
Interventions: Other: 89Zr-GC1008;   Drug: GC1008

Indicates status has not been verified in more than two years